BioCryst Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
449.34 |
608.41 |
658.45 |
737.20 |
792.77 |
881.65 |
| Przychód Δ r/r |
0.00% |
35.40% |
8.22% |
11.96% |
7.54% |
11.21% |
| Przychód (min) |
447.13 |
606.88 |
615.44 |
737.20 |
771.50 |
858.00 |
| Przychód (max) |
452.05 |
610.85 |
699.89 |
737.20 |
814.16 |
905.43 |
| EBITDA (średnia) |
-236.20 |
-319.82 |
-346.13 |
-387.52 |
-416.73 |
-463.45 |
| EBIT (średnia) |
-237.82 |
-322.01 |
-348.50 |
-390.18 |
-419.59 |
-466.63 |
| EBIT % |
-52.93% |
-52.93% |
-52.93% |
-52.93% |
-52.93% |
-52.93% |
| Zysk netto (średni) |
-72.16 |
22.55 |
119.28 |
178.75 |
203.80 |
251.76 |
| Zysk netto % |
-16.06% |
3.71% |
18.11% |
24.25% |
25.71% |
28.56% |
| EPS (średnia) |
-0.36 |
0.11 |
0.47 |
0.67 |
0.99 |
1.22 |
| Liczba analityków (Przychody) |
5 |
6 |
9 |
7 |
4 |
3 |
| Liczba analityków (EPS) |
6 |
6 |
7 |
6 |
3 |
4 |
| symbol |
BCRX |
BCRX |
BCRX |
BCRX |
BCRX |
BCRX |